Position in BMY
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$5,280,067
+$186,082 QoQ
Shares Held
87,058
-7.8% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026GAMCO INVESTORS, INC. ET AL holds $78,759,412 across 8 Drug Manufacturers - General names. BMY ranks #5 (6.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
26,339 | $24,225,822 | |
| 2 | JNJ |
Johnson & Johnson
|
80,414 | $19,656,398 | |
| 3 | PFE |
Pfizer Inc
|
589,634 | $16,556,922 | |
| 4 | MRK |
Merck & Co., Inc.
|
64,769 | $7,791,063 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
87,058 | $5,280,067 | |
| 6 | ABBV |
AbbVie Inc.
|
15,124 | $3,289,318 | |
| 7 | AMGN |
Amgen Inc
|
5,023 | $1,767,342 | |
| 8 | GRFS |
Grifols SA
|
24,000 | $192,480 |
All Filings in BMY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,280,067 | 87,058 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $5,093,985 | 94,438 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $4,545,809 | 100,794 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,726,255 | 102,101 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $6,057,709 | 99,323 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $5,915,214 | 104,583 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $5,737,655 | 110,894 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $4,628,061 | 111,439 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,321,319 | 116,565 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $6,081,363 | 118,522 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $7,135,379 | 122,939 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $7,975,844 | 124,720 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $9,222,180 | 133,057 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,738,000 | 135,344 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $10,006,983 | 140,765 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $10,893,267 | 141,471 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $11,484,259 | 157,254 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $10,433,960 | 167,345 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $10,766,277 | 181,955 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,737,267 | 175,655 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $11,516,427 | 182,424 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $11,750,466 | 189,432 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $12,519,941 | 207,662 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $13,205,127 | 224,577 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $28,820,367 | 517,050 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||